Hibbett Sports (HIBB) PT Raised to $22 at Canaccord Genuity Following 4Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- L3Harris CEO steps down amid conduct review, shares drop
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Hibbett Sports (HIBB) PT Raised to $24 at Deutsche Bank
March 25, 2019 8:05 AM EDTDeutsche Bank analyst Mike Barker raised the price target on Hibbett Sports (NASDAQ: HIBB) to $24.00 (from $21.00) while maintaining a Hold rating.
... MoreHibbett Sports (HIBB) PT Raised to $18 at BofA/Merrill Lynch
March 25, 2019 7:19 AM EDTBofA/Merrill Lynch analyst Rafe Jadrosich raised the price target on Hibbett Sports (NASDAQ: HIBB) to $18.00 (from $15.00) while maintaining a Underperform rating.
... MoreSusquehanna Upgrades Hibbett Sports (HIBB) to Positive
March 25, 2019 6:16 AM EDTSusquehanna analyst Sam Poser upgraded Hibbett Sports (NASDAQ: HIBB) from Neutral to Positive with a price target of $27.00 (from $20.00).
The analyst offers six reasons for the upgrade:
4Q19 results represented, in our view, a positive inflection point for HIBB, where results exceeded... MorePre-Open Stock Movers 03/22: (HIBB) (SRNE) (LITE) Higher; (CNAT) (ZUO) (CAL) Lower (more...)
March 22, 2019 9:21 AM EDTToday's Pre-Open Movers:
Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) 56% LOWER; announced top-line results from the companys Phase 2b ENCORE-NF clinical trial in patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH) and liver fibrosis. The trials primary endpoint was a 1 CRN fibrosis stage improvement with no worsening of steatohepatitis compared with placebo at week 72.
Hibbett Sports (NASDAQ: HIBB) 26.9% HIGHER; reported Q4 EPS of $0.57, $0.19 better... More
Hibbett Sports (HIBB) announces planned retirement of Jeff Rosenthal, President and CEO
March 22, 2019 6:37 AM EDTHibbett Sports, Inc. (NASDAQ: HIBB), an athletic specialty retailer, today announced the planned retirement of Jeff Rosenthal, President and Chief Executive Officer. The Board will commence a search process to identify the Companys next CEO, and Mr. Rosenthal will remain at the Company in his CEO capacity until a successor is named. He... More
Hibbett Sports (HIBB) Tops Q4 EPS by 19c, Offers FY Guidance
March 22, 2019 6:33 AM EDTHibbett Sports (NASDAQ: HIBB) reported Q4 EPS of $0.57, $0.19 better than the analyst estimate of $0.38. Revenue for the quarter came in at $306 million versus the consensus estimate of $282.41 million.
Comparable store sales increased 3.8% on a 13-week to 13-week... More
Consumer Edge Research Downgrades Hibbett Sports (HIBB) to Neutral
March 21, 2019 7:47 AM EDTConsumer Edge Research downgraded Hibbett Sports (NASDAQ: HIBB) from Outperform to Neutral.
For an analyst ratings summary and ratings history on Hibbett Sports click here. For more ratings news on Hibbett Sports click here.
Shares of Hibbett Sports closed at $18.54 yesterday.
... More